Pre-Commercialization
Reimbursement strategic planning is critical to the market success of your innovative technology. Many of the decisions you make now will have a tremendous impact on how Medicare and commercial payers cover and pay for your new product—and ultimately the success of your product upon commercialization.
By anticipating the reimbursement requirements associated with your technology and integrating with the clinical and regulatory requirements you are optimizing your chance for market success. RCRI can assist you in developing product specific reimbursement strategies including:
- Clinical Study Design
- Patient Outcomes
- Economic Endpoints
- Study Budgets
- Reimbursement Feasibility Analysis
- Alternative Treatment Options
- Clinical Benefit
- Cost
- Coverage, Coding and Payment Assessment
- Payer Mix Analysis
- Payer Insights
- Comprehensive Reimbursement Strategy
- Pricing Strategy
- Investor Presentation Development